A pilot single arm observational study of sofosbuvir/ledipasvir (200 + 45 mg) in 6‐ to 12‐ year old children
- 25 April 2018
- journal article
- research article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 47 (12) , 1699-1704
Abstract
Summary: Background: No available data on the use of sofosbuvir/ledipasvir combination in treatment of hepatitis C virus (HCV) infection in children 6‐ to 12‐ year old.Aim: To assess the safety and efficacy of sofosbuvir plus ledipasvir in children 6‐ to 12‐ year old with chronic HCV genotype 4 infection.Methods: This is a pilot prospective single arm observational open‐label multicentre study. A total of 20 consecutive eligible chronic HCV infected children, aged from 6‐ to 12‐ years were included in this study and treated with a fixed sofosbuvir/ledipasvir combination in half the adult dose (200/45 mg) once daily for 12 weeks. Laboratory tests including virological markers were measured at baseline, 2, 4, 8 and 12 weeks (end of treatment [EOT]), and 12 weeks after end of treatment for sustained virological response 12 (SVR12).Results: The intention‐to‐treat (ITT) SVR12 rate was 19/20 (95%; 95% CI: 76.4%‐99.1%). SVR12 was not assessed in one patient who was lost to follow‐up after showing viral negativity at the EOT12. All the remaining 19 patients (100%, 95% CI: 83.18%‐100%) who completed the full protocol and follow‐up visits achieved SVR12 with normal liver, haematological, and renal function tests and no side effects or fatalities.Conclusions: This pilot study demonstrated that the fixed dose sofosbuvir/ledipasvir combination could be safe and effective treatment in children 6‐ to 12‐ years with chronic hepatitis C genotype 4 infection. Our pilot results might encourage larger and multicentre studies in this age group.Keywords
This publication has 18 references indexed in Scilit:
- Childhood hepatitis C virus infection: An Australian national surveillance study of incident cases over five yearsJournal of Paediatrics and Child Health, 2015
- Reducing the neglected burden of viral hepatitis in Africa: Strategies for a global approachJournal of Hepatology, 2015
- Hepatitis C drugs not reaching poorNature, 2014
- Burden of pediatric hepatitis CWorld Journal of Gastroenterology, 2013
- Expected and Actual Case Ascertainment and Treatment Rates for Children Infected with Hepatitis C in Florida and the United States: Epidemiologic Evidence from Statewide and Nationwide SurveysThe Journal of Pediatrics, 2012
- HCV burden of infection in Egypt: results from a nationwide surveyJournal of Viral Hepatitis, 2012
- Hepatitis C virus infection among healthy Egyptian children: prevalence and risk factorsJournal of Viral Hepatitis, 2011
- Hepatitis C genotype 4Hepatology, 2008
- Approach to the Infant with Cholestasis2007
- The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in EgyptThe Lancet, 2000